Clinical outcomes of nalidixic acid, ceftriaxone, and multidrug-resistant nontyphoidal salmonella infections compared with pansusceptible infections in FoodNet sites, 2006-2008.

@article{Krueger2014ClinicalOO,
  title={Clinical outcomes of nalidixic acid, ceftriaxone, and multidrug-resistant nontyphoidal salmonella infections compared with pansusceptible infections in FoodNet sites, 2006-2008.},
  author={Amy Krueger and Sharon A. Greene and Ezra J. Barzilay and Olga L. Henao and Duc J. Vugia and Samir Hanna and Stephanie D Meyer and Kirk P. Smith and Gary Pecic and Dina Hoefer and Patricia M. Griffin},
  journal={Foodborne pathogens and disease},
  year={2014},
  volume={11 5},
  pages={335-41}
}
BACKGROUND Nontyphoidal Salmonella causes an estimated 1.2 million infections, 23,000 hospitalizations, and 450 deaths annually in the United States. Most illnesses are self-limited; however, treatment with antimicrobial agents can be life-saving for invasive infections. METHODS The Foodborne Diseases Active Surveillance Network and the National Antimicrobial Resistance Monitoring System collaborated on a prospective cohort study of patients with nontyphoidal Salmonella bloodstream and… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 7 times over the past 90 days. VIEW TWEETS

Similar Papers

Loading similar papers…